Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Alexion Pharmaceuticals, Inc.
(NQ:
ALXN
)
99.88
USD
-0.69 (-0.69%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 23, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Alexion Pharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Notable Two Hundred Day Moving Average Cross - ALXN
Today 12:34 EDT
In trading on Thursday, shares of Alexion Pharmaceuticals Inc. (ALXN) crossed below their 200 day moving average of $98.73, changing hands as low as $98.00 per share.
Read More
category
Stocks
from
Market News Video
Charting a persistent May uptrend
May 21, 2013
The major U.S. stock benchmarks have knifed to less-charted territory, and the technical price action is holding true to form.
Read More
category
Retail
,
Opinion
,
MYGN
, and 16 more.
from
MarketWatch
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences...
Read More
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 35 more.
from
Latest Articles from Benzinga.com
Top Stocks Rise; Ocwen Clears Buy Point In Big Volume
May 10, 2013
Most Sector Leaders rebounded Friday, many in strong volume, as the general market ended higher. Alexion Pharmaceuticals (ALXN) was the biggest gainer, bolting 5.95, or 6%, to 104.14 in healthy volume....
Read More
category
Top Sectors
from
Investor's Business Daily - Investing RSS
Orphan Drug Companies Might Not Find A Parent
May 08, 2013
by Olga Oksman
Read More
category
NASDAQ:VRTX
,
EURONEXTPARIS:SNY
,
NASDAQ:NPSP
, and 2 more.
from
Forbes Real Time
Alexion Pharmaceuticals Crosses Below its 10-day MA (ALXN)
May 07, 2013
from
Comtex SmarTrend® News Briefs
Goldman Sachs’ Equity Strategist Names 40 Most Undervalued Stocks
May 06, 2013
Goldman Sachs’ chief US equity strategist David Kostin doesn’t see much upside to the S&P 500 through the end of this year. But he expects plenty of individual stocks to outperform. In Kostin’s most...
Read More
category
altr
,
crm
,
emn
, and 39 more.
from
WallStreetInsanity
Goldman Sachs’ Equity Strategist Names 40 Most Undervalued Stocks
May 06, 2013
from
WallStreetInsanity
IBB, AMGN, CELG, ALXN: ETF Inflow Alert
May 06, 2013
Symbols mentioned in this story: IBB, AMGN, CELG, ALXN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Read More
category
ETFs
from
ETF Channel
American Real Disposable Income Collapses in First Quarter of 2013
April 30, 2013
category
Pharmaceuticals
,
Exchanges
from
Trefis
Alexion Becomes Newest Member Of Sector Leaders
April 29, 2013
A few more stocks have reached Sector Leader status the past week, bringing the total to seven in Monday's edition. Alexion Pharmaceuticals (ALXN) is the most recent addition. The stock Monday was off...
Read More
category
Top Sectors
from
Investor's Business Daily - Investing RSS
Short Sellers Move into Celgene, Regeneron
April 26, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the first two weeks of April. The number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN ), Amgen...
Read More
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 34 more.
from
Latest Articles from Benzinga.com
IBB, CELG, BIIB, ALXN: Large Inflows Detected at ETF
April 26, 2013
Symbols mentioned in this story: IBB, CELG, BIIB, ALXN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Read More
category
ETFs
from
ETF Channel
US STOCKS-Wall St gains on earnings, data, but S&P record a hurdle
April 25, 2013
* Data points to healthy job market despite sub-par growth
Read More
category
companyNews
from
Reuters: Company News
Alexion Pharmaceuticals (ALXN) Fundamentals Strong - Analyst
April 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8279284 for the full story.
Read More
from
StreetInsider.com News Articles
Alexion Pharmaceuticals, Inc. (ALXN) Tops Q1 EPS by 4c; Boosts Outlook
April 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8277132 for the full story.
Read More
from
StreetInsider.com News Articles
Trading Radar for 04/25: Exxon, (XOM), Dow (DOW), 3M (MMM), Hershey (HSY), UPS (UPS), Expedia (EXPE) Report
April 24, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8276525 for the full story.
Read More
from
StreetInsider.com News Articles
Management Comments on Thursday Could Boost Shares of Alexion (ALXN)
April 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8268396 for the full story.
Read More
from
StreetInsider.com News Articles
Alexion Pharmaceuticals Crosses Below its 10-day MA (ALXN)
April 15, 2013
from
Comtex SmarTrend® News Briefs
Notable ETF Inflow Detected - IBB, ALXN, BIIB, PRGO
April 11, 2013
Symbols mentioned in this story: IBB, ALXN, BIIB, PRGO Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Read More
category
ETFs
from
ETF Channel
Short Sellers Move Out of Amgen, Celgene, Pharmacyclics
April 10, 2013
The short interest in biotech and emerging pharmaceutical companies was mixed in the final two weeks of March. The number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN ), Arena...
Read More
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 32 more.
from
Latest Articles from Benzinga.com
Myths In The Pricing Of New Drugs
April 02, 2013
There has been renewed debate on the pricing of new drugs. This started with comments made by GSK CEO, Sir Andrew Witty, as reported by Ben Hirschler at Reuters. Witty claimed that he expected that...
Read More
category
NYSE:NVS
,
NYSE:SNY
,
NYSE:GSK
, and 2 more.
from
Forbes Real Time
Alexion (ALXN), BioMarin (BMRN) Could Offer Treatment for Sick Portfolio - Cramer
April 02, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8224139 for the full story.
Read More
from
StreetInsider.com News Articles
Cramer: Small Drug Stocks with Promising Pipelines
April 01, 2013
If you're looking for a small stock with big return potential, Jim Cramer thinks you should consider this.
Read More
category
BioMarin Pharmaceutical Inc
,
Biotechnology
,
Mad Money for Mobile
, and 10 more.
from
CNBC.com News
BBRY and TSLA added to NASDAQ Active Gainers Watch List at Growing Stock Report
April 01, 2013
from
ACCESSWIRE
Stocks Crossing 50-Day SMA 04/01: (BBRY) (ALXN) (SODA) Above; (CSCO) (ZNGA) (BCRX) Below
April 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8222383 for the full story.
Read More
from
StreetInsider.com News Articles
IBB, AMGN, CELG, ALXN: Large Inflows Detected at ETF
April 01, 2013
Symbols mentioned in this story: IBB, AMGN, CELG, ALXN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Read More
category
ETFs
from
ETF Channel
Analysts Sound Horn on Alexion (ALXN)… Buy Weakness
March 28, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8217629 for the full story.
Read More
from
StreetInsider.com News Articles
Buy Alexion on Weakness After FDA Warning Letter, Suggest Piper Jaffray Analyst
March 28, 2013
Ian Somaiya, an analyst for Piper Jaffray, suggests buying Alexion (NASDAQ: ALXN ) on recent weakness over an FDA warning letter. He believes that Alexion will reach an agreement with the FDA on how to...
Read More
category
Benzinga
,
News
,
FDA
, and 1 more.
from
Latest Articles from Benzinga.com
Alexion Pharma (ALXN) Receives cGMP Warning Letter from FDA for R.I. Facility
March 28, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8216757 for the full story.
Read More
from
StreetInsider.com News Articles
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.